Comparison
8p11 2 Deletion Syndrome C4304505 vs Abca1 Related Disorder Cn239173
Clinical comparison between 8p11 2 Deletion Syndrome and Abca1 Related Disorder CN239173 for differential diagnosis and treatment planning.
8p11 2 Deletion Syndrome C4304505
A genetic condition caused by deletion of material from chromosome 8. It may lead to developmental delays, distinctive facial features, and other health concerns. Treatment focuses on addressing specific symptoms with multidisciplinary support.
Abca1 Related Disorder Cn239173
A disorder affecting how the body processes cholesterol and fats due to ABCA1 gene changes. Can lead to very low HDL cholesterol and increased risk of heart disease. Management includes lipid monitoring, diet modifications, and cardiovascular risk reduction.
6 comparison axes
Onset
8p11 2 Deletion Syndrome C4304505
0-null
Abca1 Related Disorder Cn239173
1-20
Onset patterns differ
Severity
8p11 2 Deletion Syndrome C4304505
moderate
Abca1 Related Disorder Cn239173
moderate
Different severity levels
Chronic
8p11 2 Deletion Syndrome C4304505
Chronic
Abca1 Related Disorder Cn239173
Chronic
Differing course
Communicable
8p11 2 Deletion Syndrome C4304505
No
Abca1 Related Disorder Cn239173
No
Different transmission
Body System
8p11 2 Deletion Syndrome C4304505
congenital
Abca1 Related Disorder Cn239173
metabolic
Same/different system
Category
8p11 2 Deletion Syndrome C4304505
genetic
Abca1 Related Disorder Cn239173
metabolic
Different category
Bottom line
8p11-2-deletion-syndrome-C4304505 and abca1-related-disorder-CN239173 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 8p11 2 Deletion Syndrome C4304505 | Abca1 Related Disorder Cn239173 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Developmental delay may be present from early life. | Development is not the defining feature in source data. | Moderate |
| Facial features | Distinctive facial features may occur. | No characteristic facial pattern is established here. | Moderate |
| Lipid abnormality | A primary lipid phenotype is not described. | Very low HDL cholesterol may be found. | High |
When to favor each condition
Choose 8p11 2 Deletion Syndrome C4304505 when
Congenital developmental concerns
Source data emphasize early developmental delay and congenital genetic etiology.
Moderate
Suspected chromosomal deletion
The condition is defined by loss of chromosome 8 material.
High
Multiple congenital features
Facial and other health concerns may require syndrome evaluation.
Moderate
Choose Abca1 Related Disorder Cn239173 when
Unexplained low HDL
ABCA1 changes affect cholesterol and fat handling.
High
Cardiovascular risk assessment
Source data link the disorder with increased heart-disease risk.
Moderate
Metabolic rather than congenital presentation
The supplied category and body system are metabolic.
Moderate
How key tests differ
| Test | 8p11 2 Deletion Syndrome C4304505 | Abca1 Related Disorder Cn239173 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify deletion involving 8p11.2. | Not expected to define an ABCA1 disorder. | A deletion supports the left condition but needs clinical correlation. |
| ABCA1 genetic testing | Not the defining test in the source description. | May identify ABCA1 gene changes. | A variant requires laboratory and clinician interpretation. |
| Lipid profile | No characteristic lipid result is established here. | May show very low HDL; exact cutoff not supplied. | Low HDL is a finding, not by itself a diagnosis. |
Prognosis comparison
8p11 2 Deletion Syndrome C4304505
- Outcome
- Chronic course with variable developmental and health needs; exact prognosis is not established.
- Factors
- Deleted region, associated anomalies, and access to supportive care may influence outcomes.
Abca1 Related Disorder Cn239173
- Outcome
- Chronic lipid disorder with possible cardiovascular risk; individual outcome is not established.
- Factors
- HDL level, other risk factors, diet, and cardiovascular prevention may matter.
Time frame: Both are described as chronic; onset data suggest earlier recognition on the left.
No mortality, prevalence, or treatment-dose comparison is supported by the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complications | Delays and related support needs may occur. Not established as a core complication. Severity and specific deficits vary and are not quantified here. |
| Cardiovascular disease | Not identified as the principal risk in source data. Increased heart-disease risk may occur. Absolute risk and mortality are not established by these data. |
| Other health concerns | Additional congenital concerns may require specialist care. Lipid-related complications are the main described concern. Individual complications should not be assumed without evaluation. |
Patient education highlights
- HighDifferent causes
One involves chromosome 8 deletion; the other involves ABCA1 and lipid processing.
- HighTest result versus diagnosis
A low HDL result or genetic finding needs clinician confirmation and context.
- MediumCare focus
Left care is multidisciplinary and symptom-based; right care emphasizes lipids, diet, and heart-risk reduction.